News

We are delighted to announce that Denis Patrashev will take over responsibility for Aristo Pharma Russia as the new General Director on October 1, 2025. Denis is on board as Deputy General Director since September 1. Within the month of September Denis takes over the lead, getting to know the team and receiving a handover of business processes. 

In addition to his university degrees in biophysics, PhD in clinical pharmacology and MBA in marketing and economics, Denis can look back on a long career started at Berlin Chemie as a medical representative and product manager. In the following years he took on further responsibility as Country Manager at GSK Belarus and General Manager at Galderma Russia. After several projects for Sandoz and Innovapharm, Denis most recently served as CEO for Norwegian Fish Oil.

Jonas Tryggvason, former General Director of Aristo Pharma Russia, has decided to leave the Company to enjoy his well-deserved retirement. Jonas joined Aristo Pharma Group in January 2020 as a Head of Esparma GmbH Representative Office responsible for Russian and CIS markets. Over the next five years Jonas achieved incredible progress by opening a fully-fledged pharmaceutical company Aristo Pharma LLC with ninety employees, with a modern office and a pharmaceutical warehouse in Moscow. 

"Aristo has become an important part of my professional history. Aristo today has strong and stable position in the Russian pharmaceutical market despite the complicated economic situation. A very professional team has been formed and business processes are constantly being improved. Aristo potential is great and the company has good opportunities for growth and further development - all the conditions for successful future are created" - says Jonas Tryggvason.